Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1075863
Max Phase: Preclinical
Molecular Formula: C40H55N9O5
Molecular Weight: 741.94
Molecule Type: Small molecule
Associated Items:
ID: ALA1075863
Max Phase: Preclinical
Molecular Formula: C40H55N9O5
Molecular Weight: 741.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N(C)CCc1ccccn1
Standard InChI: InChI=1S/C40H55N9O5/c1-3-4-5-6-7-8-9-10-14-37(51)46-34(23-31-25-41-27-44-31)38(52)47-35(24-32-26-42-28-45-32)39(53)48-36(22-29-15-17-33(50)18-16-29)40(54)49(2)21-19-30-13-11-12-20-43-30/h11-13,15-18,20,25-28,34-36,50H,3-10,14,19,21-24H2,1-2H3,(H,41,44)(H,42,45)(H,46,51)(H,47,52)(H,48,53)/t34-,35-,36-/m0/s1
Standard InChI Key: XTWPUBVVNIJMOQ-KVBYWJEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 741.94 | Molecular Weight (Monoisotopic): 741.4326 | AlogP: 3.95 | #Rotatable Bonds: 24 |
Polar Surface Area: 198.09 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 6.95 | CX LogP: 3.04 | CX LogD: 2.92 |
Aromatic Rings: 4 | Heavy Atoms: 54 | QED Weighted: 0.06 | Np Likeness Score: -0.40 |
1. Tan KT, Guiu-Rozas E, Bon RS, Guo Z, Delon C, Wetzel S, Arndt S, Alexandrov K, Waldmann H, Goody RS, Wu YW, Blankenfeldt W.. (2009) Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors., 52 (24): [PMID:19894725] [10.1021/jm901117d] |
Source(1):